viral
infect
involv
pathogenesi
blood
autoimmun
diseas
hemolyt
anemia
thrombocytopenia
although
antigen
mimicri
propos
major
mechan
virus
could
trigger
develop
diseas
easi
understand
wide
differ
virus
might
induc
blood
autoimmun
diseas
sole
mechan
mice
infect
lactat
dehydrogenaseelev
viru
ldv
mous
hepat
viru
treat
antierythrocyt
antiplatelet
monoclon
autoantibodi
dose
insuffici
induc
clinic
diseas
infect
sharpli
enhanc
pathogen
autoantibodi
lead
sever
anemia
thrombocytopenia
effect
observ
antibodi
induc
diseas
phagocytosi
moreov
phagocyt
activ
macrophag
infect
mice
increas
enhanc
effect
infect
autoantibodymedi
pathogen
strongli
suppress
treatment
mice
clodronatecontain
liposom
final
diseas
induc
ldv
administr
autoantibodi
larg
suppress
anim
defici
gammainterferon
receptor
togeth
observ
suggest
virus
may
trigger
autoantibodymedi
anemia
thrombocytopenia
activ
macrophag
gammainterferon
product
mechan
may
account
pathogen
similar
multipl
infecti
agent
involv
virus
pathogenesi
autoimmun
diseas
mediat
autoantibodi
includ
blood
diseas
hemolyt
anemia
thrombocytopenia
report
patient
experiment
model
children
acut
immun
thrombocytopen
purpura
itp
often
follow
viral
infect
interestingli
caus
infect
may
due
differ
virus
influenza
viru
rubella
viru
mump
parvoviru
cytomegaloviru
epsteinbarr
viru
varicella
zoster
viru
autoantibodi
secret
cours
infect
opson
platelet
lead
destruct
phagocytosi
cell
reticuloendotheli
system
especi
macrophag
result
platelet
drop
clinic
symptom
includ
petechia
sever
case
bleed
develop
although
exclud
mechan
polyclon
b
cell
activ
antiidiotyp
respons
alter
self
antigen
viru
enhanc
antigen
present
might
play
role
virallytrigg
diseas
molecular
mimicri
epitop
share
platelet
infecti
agent
suggest
mainli
explain
initi
product
autoantibodi
spread
autoimmun
respons
platelet
determin
necessarili
share
viru
may
respons
develop
itp
proinflammatori
cytokin
like
gammainterferon
ifng
produc
higher
level
itp
patient
normal
individu
may
contribut
full
express
diseas
howev
wherea
involv
virus
etiolog
itp
seem
well
establish
might
difficult
understand
infecti
agent
carri
distinct
antigen
epitop
may
trigger
molecular
mimicri
autoantibodi
respons
similarli
target
platelet
determin
although
relationship
autoimmun
hemolyt
anemia
aiha
virus
shown
clearli
itp
mani
case
aiha
report
infect
virus
divers
hepat
c
virus
human
immunodefici
epsteinbarr
viru
rubella
viru
varicella
viru
thu
may
hypothes
differ
virus
trigger
two
autoantibodymedi
diseas
similar
mechan
mani
experiment
model
itp
aiha
report
inject
mice
polyclon
monoclon
antibodi
rais
platelet
red
blood
cell
rbc
includ
switch
variant
deriv
monoclon
autoantibodi
allow
analysi
differ
mechan
involv
destruct
target
cell
antiplatelet
autoantibodi
spontan
produc
male
mice
lead
thrombocytopenia
howev
thrombocytopenia
aris
context
complex
autoimmun
syndrom
reminisc
human
system
autoimmun
diseas
rather
organspecif
itp
similarli
nzb
mice
develop
aiha
mediat
antierythrocyt
autoantibodi
produc
concomitantli
autoantibodi
divers
specif
although
distinct
mechan
antierythrocyt
antiplatelet
autoantibodi
respons
elicit
mice
immun
rat
rbc
platelet
administr
rat
erythrocyt
normal
mice
result
activ
autoreact
b
lymphocyt
recogn
differ
share
epitop
includ
rbc
antigen
lead
moder
anemia
immun
mice
infect
ldv
result
faster
antirbc
autoantibodi
respons
without
enhanc
anemia
similarli
product
probabl
molecular
mimicri
antiplatelet
autoantibodi
react
autoantigen
follow
immun
strain
normal
mice
rat
platelet
result
thrombocytopenia
moder
transient
antiplatelet
autoantibodi
product
also
report
interspeci
platelet
immun
marmoset
anim
model
mimic
effect
infect
pathogenesi
human
itp
aiha
mice
infect
viru
develop
transient
thrombocytopenia
may
result
secret
antiplatelet
autoantibodi
togeth
consequ
viral
infect
paraplegia
infecti
agent
induc
polyclon
b
lymphocyt
activ
trypanosoma
brucei
trigger
secret
autoantibodi
recogn
divers
autoantigen
includ
erythrocyt
infect
mice
lymphocyt
choriomening
viru
lcmv
result
anemia
central
origin
anim
may
depend
natur
killer
cell
lymphocyt
activ
secret
interferon
ifn
ah
howev
mice
docil
strain
lcmv
trigger
peripher
hemolyt
anemia
correl
product
antierythrocyt
autoantibodi
recogn
antigen
although
antierythrocyt
autoantibodi
product
appar
result
either
molecular
mimicri
b
lymphocyt
polyclon
activ
mechan
induc
infect
remain
determin
effect
viral
infect
antibodymedi
blood
autoimmun
diseas
test
two
differ
model
hemolyt
anemia
induc
normal
mice
administr
monoclon
antierythrocyt
autoantibodi
distinct
pathogen
mechan
lead
diseas
normal
anim
antibodi
includ
autoantibodi
induc
anemia
phagocytosi
opson
erythrocyt
cell
reticuloendotheli
system
autoantibodi
trigger
agglutin
rbc
sequest
spleen
liver
moreov
complement
may
also
increas
pathogen
autoantibodi
isotyp
mice
infect
lactat
dehydrogenaseelev
viru
ldv
mous
arteriviru
display
dramat
enhanc
anemia
induc
autoantibodi
antibodi
suggest
viru
may
increas
phagocytosi
opson
erythrocyt
similarli
ldv
exacerb
thrombocytopenia
induc
administr
normal
mice
polyclon
monoclon
antiplatelet
antibodi
includ
autoantibodi
deriv
mice
integrin
iib
chain
antibodi
tabl
mous
hepat
viru
coronaviru
enhanc
effect
pathogen
antiplatelet
antibodi
result
concomit
administr
ldv
antiplatelet
antibodi
mice
develop
petechia
reminisc
observ
patient
immun
thrombocytopen
purpura
sever
line
evid
point
toward
phagocytosi
major
mechan
involv
exacerb
effect
virus
antibodymedi
blood
autoimmun
diseas
tabl
first
f
abv
fragment
antiplatelet
polyclon
antibodi
induc
thrombocytopenia
even
infect
anim
indic
fc
fragment
recogn
receptor
may
mediat
phagocytosi
requir
antibodi
pathogen
effect
second
vivo
treatment
total
igg
block
fc
receptor
phagocyt
cell
ivig
clodronatecontain
liposom
suppress
macrophag
thu
inhibit
phagocytosi
autoantibodyco
target
cell
prevent
develop
antibodymedi
thrombocytopenia
ldvinfect
mice
third
histolog
analysi
show
vivo
phagocytosi
much
larger
number
erythrocyt
liver
ldvinfect
mice
receiv
antirbc
monoclon
autoantibodi
control
anim
final
abil
macrophag
ldvinfect
mice
phagocytos
ex
vivo
erythrocyt
opson
monoclon
autoantibodi
enhanc
compar
macrophag
obtain
uninfect
anim
macrophag
stimul
cytokin
growth
factor
granulocytemacrophag
colonystimul
factor
gmcsf
lead
enhanc
anemia
mediat
antierythrocyt
monoclon
autoantibodi
viral
infect
includ
ldv
frequent
trigger
secret
ifng
potent
macrophag
activ
also
fig
hypothesi
involv
viral
infect
autoantibodymedi
blood
autoimmun
diseas
antiplatelet
antierythrocyt
autoantibodi
moder
pathogen
could
produc
respons
first
stimulu
antigenpres
cell
helper
lymphocyt
b
lymphocyt
infect
first
pathogen
may
share
epitop
self
antigen
may
polyclon
activ
lymphocyt
diseas
could
induc
cascad
cellular
molecular
mechan
involv
cytokin
secret
target
cell
macrophag
dendrit
cell
respons
infect
second
viru
follow
ifng
secret
cell
like
nk
cell
increas
phagocyt
activ
macrophag
result
enhanc
clearanc
autoantibodyco
platelet
rbc
produc
cours
ldv
infect
may
postul
cascad
cell
activ
cytokin
product
lead
ifng
secret
natur
killer
cell
identifi
major
sourc
secret
cytokin
infect
viru
ifng
involv
exacerb
autoantibodymedi
hemolyt
anemia
thrombocytopenia
induc
ldv
shown
diseas
prevent
mice
defici
receptor
mice
tabl
observ
may
hypothes
develop
blood
antibodymedi
autoimmun
diseas
sometim
requir
two
success
event
fig
product
autoantibodi
moder
pathogen
remain
clinic
silent
may
induc
b
lymphocyt
polyclon
activ
antigen
mimicri
mechan
stimulu
like
first
infecti
agent
exacerb
pathogen
autoantibodi
lead
diseas
cascad
event
trigger
second
infect
one
mani
differ
virus
involv
secret
proinflammatori
cytokin
infect
target
cell
macrophag
dendrit
cell
follow
ifng
product
either
natur
killer
cell
lymphocyt
final
enhanc
phagocyt
activ
macrophag
toler
preproinsulin
type
diabet
jaeckel
et
al
nat
immunol
report
toler
transgen
overexpress
preproinsulin
substanti
reduc
onset
sever
type
diabet
nonobes
diabet
mice
howev
mice
still
develop
type
diabet
support
assumpt
insulin
key
absolut
essenti
autoantigen
author
suggest
result
consist
idea
human
locu
control
suscept
type
diabet
regul
intrathym
preproinsulin
express
